These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28137898)

  • 1. Mycobacterium chelonae hand infection after steroid injection in a patient with rheumatoid arthritis receiving long-term linezolid therapy.
    Olesen JS; Wang M; Wejse C
    BMJ Case Rep; 2017 Jan; 2017():. PubMed ID: 28137898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction therapy with linezolid/clarithromycin combination for Mycobacterium chelonae skin infections in immunocompromised hosts.
    Parize P; Hamelin A; Veziris N; Morand PC; Guillemain R; Lortholary O; Dupin N
    J Eur Acad Dermatol Venereol; 2016 Jan; 30(1):101-5. PubMed ID: 25677464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of Antimicrobial Susceptibilities of Rapidly Growing Mycobacteria].
    Özkarataş MH; Arslan N; Esen N; Özkütük AA
    Mikrobiyol Bul; 2023 Apr; 57(2):220-237. PubMed ID: 37067207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
    Gui J; Wang F; Hong CY; Li JL; Liang J
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mycobacterium chelonae tenosynovitis of the hand.
    Mateo L; Rufí G; Nolla JM; Alcaide F
    Semin Arthritis Rheum; 2004 Dec; 34(3):617-22. PubMed ID: 15609266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro bactericidal activity of antibiotic combinations against clinical isolates of Mycobacterium chelonae.
    Cremades R; Santos A; Rodríguez JC; Garcia-Pachon E; Ruiz M; Royo G
    J Chemother; 2008 Feb; 20(1):43-7. PubMed ID: 18343742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin.
    Wallace RJ; Brown BA; Onyi GO
    J Infect Dis; 1992 Aug; 166(2):405-12. PubMed ID: 1386098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility and minimum inhibitory concentration distribution of common clinically relevant non-tuberculous mycobacterial isolates from the respiratory tract.
    He G; Wu L; Zheng Q; Jiang X
    Ann Med; 2022 Dec; 54(1):2500-2510. PubMed ID: 36120867
    [No Abstract]   [Full Text] [Related]  

  • 9. Mycobacterium chelonae infection in a tattoo site.
    Preda VA; Maley M; Sullivan JR
    Med J Aust; 2009 Mar; 190(5):278-9. PubMed ID: 19296796
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
    Abshire R; Cockrum P; Crider J; Schlech B
    Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical trial of clarithromycin for cutaneous (disseminated) infection due to Mycobacterium chelonae.
    Wallace RJ; Tanner D; Brennan PJ; Brown BA
    Ann Intern Med; 1993 Sep; 119(6):482-6. PubMed ID: 8357113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterium chelonae (M. chelonae subspecies chelonae): report of a patient with a sporotrichoid presentation who was successfully treated with clarithromycin and ciprofloxacin.
    Zahid MA; Klotz SA; Goldstein E; Bartholomew W
    Clin Infect Dis; 1994 Jun; 18(6):999-1001. PubMed ID: 8086568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel.
    Hershko Y; Adler A
    Microb Drug Resist; 2023 Jul; 29(7):302-308. PubMed ID: 37219996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone.
    Hamam RN; Noureddin B; Salti HI; Haddad R; Khoury JM
    Ophthalmology; 2006 Jun; 113(6):950-4. PubMed ID: 16647126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcome of the chronic flexor tenosynovitis in the hand caused by non-tuberculous mycobacterium treated by extensive tenosynovectomy and drugs.
    Yano K; Yoshida T; Minoda Y; Horiki M; Denno K; Yoneda M; Tada K
    J Plast Surg Hand Surg; 2013 Dec; 47(6):434-7. PubMed ID: 23875916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iatrogenic Mycobacterium abscessus infection in a trigger finger.
    Calif E; Neuberger A; Stahl S
    Indian J Tuberc; 2015 Apr; 62(2):114-6. PubMed ID: 26117482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Achilles tendon infection due to Mycobacterium chelonae.
    Lui TH; Chan KB
    J Foot Ankle Surg; 2014; 53(3):350-2. PubMed ID: 24529751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mycobacterium chelonae myositis].
    Hajjaji N; Cattier B; Lanotte P; Legras A; Perrotin D
    Presse Med; 2004 Dec; 33(21):1519-20. PubMed ID: 15614176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disseminated cutaneous Mycobacterium chelonae infection after injection of bovine embryonic cells.
    Valencia IC; Weiss E; Sukenik E; Kerdel FA
    Int J Dermatol; 1999 Oct; 38(10):770-3. PubMed ID: 10561050
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of Topical Besifloxacin in the Treatment of Mycobacterium chelonae Ocular Surface Infections.
    Nguyen AT; Hong AR; Baqai J; Lubniewski AJ; Huang AJ
    Cornea; 2015 Aug; 34(8):967-71. PubMed ID: 26075451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.